Search
for
Sort by
Research 211–240 of 1000+
- Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers
- Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
- Pharmacology of anabolic steroids
- Pharmacology of antiandrogens
- 5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment
- Inhibition of 5α-Reductase, IL-6 Secretion, and Oxidation Process of Equisetum debile Roxb. ex Vaucher Extract as Functional Food and Nutraceuticals Ingredients
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Pharmacological management of polycystic ovary syndrome
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Pharmacology of Induced Artificial Platelets in Regenerative Medicine: Beyond Transfusion
- Pharmacological activities of extracts from different parts of <i>Cirsium japonicum</i> var <i>spinossimum</i>
- A potential review of its traditional uses, Phytochemistry, pharmacology, and toxicity of Plumbago zeylanica
- Eclipta alba (Family: Asteraceae): A review of botanical, ethnopharmacological, phytochemical and pharmacological studies
- A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells
- Pharmacological and Histochemical Screening for Hair Growth-Promoting Activity of Daucus carota Herbal Gel.
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- The pharmacology of methotrexate
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects